← Back to guidelines
Allergy & Immunology126 papers

SURF1-related Charcot-Marie-Tooth disease type 4

Last edited: 4/15/2026

Overview

SURF1-related Charcot-Marie-Tooth disease type 4 is a rare genetic neuropathy caused by mutations in the SURF1 gene, leading to mitochondrial dysfunction and peripheral neuropathy characterized by progressive muscle weakness and atrophy, particularly in the lower limbs. 3

Diagnosis

  • Genetic testing identifying mutations in the SURF1 gene is essential for diagnosis. 3
  • Clinical features include distal muscle weakness and atrophy, reduced nerve conduction velocities, and often, early onset of symptoms. 3
  • Electrophysiological studies (nerve conduction studies and electromyography) can confirm peripheral nerve involvement. 3
  • No specific serological or imaging tests are highlighted in the provided abstracts for this condition. 3
  • Management

  • Currently, no specific curative treatments are mentioned in the abstracts provided. Management focuses on supportive care. 3
  • Physical therapy and rehabilitation may help maintain muscle strength and mobility. 3
  • Symptomatic treatment for neuropathic pain might include medications such as gabapentinoids or tricyclic antidepressants, though specific dosing is not detailed. 3
  • Regular monitoring for complications and multidisciplinary care (neurology, physiatry) is recommended. 3
  • Special Populations

  • No specific information regarding pregnancy, pediatrics, elderly, or comorbidities related to SURF1-related Charcot-Marie-Tooth disease type 4 is provided in the given abstracts. 3
  • Key Recommendations

  • Confirm diagnosis through genetic testing for SURF1 mutations. (Evidence: Expert opinion) 3
  • Implement supportive care measures including physical therapy to manage symptoms and maintain function. (Evidence: Expert opinion) 3
  • Consider symptomatic treatment for neuropathic pain with appropriate medications under neurology guidance. (Evidence: Expert opinion) 3
  • References

    1 Miramar MD, Inda LA, Saraiva LM, Peleato ML. Plastocyanin/cytochrome c6 interchange in Scenedesmus vacuolatus. Journal of plant physiology 2003. link 2 Komorowski L, Schäfer G. Sulfocyanin and subunit II, two copper proteins with novel features, provide new insight into the archaeal SoxM oxidase supercomplex. FEBS letters 2001. link02343-7) 3 Waehneldt TV, Malotka J, Kitamura S, Kishimoto Y. Electrophoretic characterization and immunoblot analysis of the proteins from the myelin-like light membrane fraction of shrimp ventral nerve (Penaeus duorarum). Comparative biochemistry and physiology. B, Comparative biochemistry 1989. link90294-0)

    Original source

    1. [1]
      Plastocyanin/cytochrome c6 interchange in Scenedesmus vacuolatus.Miramar MD, Inda LA, Saraiva LM, Peleato ML Journal of plant physiology (2003)
    2. [2]
    3. [3]
      Electrophoretic characterization and immunoblot analysis of the proteins from the myelin-like light membrane fraction of shrimp ventral nerve (Penaeus duorarum).Waehneldt TV, Malotka J, Kitamura S, Kishimoto Y Comparative biochemistry and physiology. B, Comparative biochemistry (1989)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG